Ultragenyx Pharmaceutical Statistics

Total Valuation

RARE has a market cap or net worth of $3.45 billion. The enterprise value is $3.77 billion.

Market Cap	3.45B
Enterprise Value	3.77B

Important Dates

The next estimated earnings date is Thursday, July 31, 2025, after market close.

Earnings Date	Jul 31, 2025
Ex-Dividend Date	n/a

Share Statistics

RARE has 94.38 million shares outstanding. The number of shares has increased by 21.44% in one year.

Current Share Class	94.38M
Shares Outstanding	94.38M
Shares Change (YoY)	+21.44%
Shares Change (QoQ)	+0.63%
Owned by Insiders (%)	3.56%
Owned by Institutions (%)	96.38%
Float	90.98M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.91
Forward PS	4.92
PB Ratio	24.27
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	6.39
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.40, with a Debt / Equity ratio of 5.88.

Current Ratio	2.40
Quick Ratio	2.05
Debt / Equity	5.88
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-8.35

Financial Efficiency

Return on equity (ROE) is -377.06% and return on invested capital (ROIC) is -30.38%.

Return on Equity (ROE)	-377.06%
Return on Assets (ROA)	-24.51%
Return on Invested Capital (ROIC)	-30.38%
Return on Capital Employed (ROCE)	-50.34%
Revenue Per Employee	$456,483
Profits Per Employee	-$424,713
Employee Count	1,294
Asset Turnover	0.45
Inventory Turnover	18.87

Taxes

In the past 12 months, RARE has paid $2.45 million in taxes.

Income Tax	2.45M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -9.89% in the last 52 weeks. The beta is 0.24, so RARE's price volatility has been lower than the market average.

Beta (5Y)	0.24
52-Week Price Change	-9.89%
50-Day Moving Average	36.55
200-Day Moving Average	43.64
Relative Strength Index (RSI)	48.18
Average Volume (20 Days)	1,151,050

Short Selling Information

The latest short interest is 6.08 million, so 6.44% of the outstanding shares have been sold short.

Short Interest	6.08M
Short Previous Month	5.55M
Short % of Shares Out	6.44%
Short % of Float	6.68%
Short Ratio (days to cover)	5.87

Income Statement

In the last 12 months, RARE had revenue of $590.69 million and -$549.58 million in losses. Loss per share was -$5.88.

Revenue	590.69M
Gross Profit	-182.32M
Operating Income	-513.57M
Pretax Income	-586.86M
Net Income	-549.58M
EBITDA	-477.88M
EBIT	-513.57M
Loss Per Share	-$5.88

Full Income Statement

Balance Sheet

The company has $494.44 million in cash and $889.70 million in debt, giving a net cash position of -$326.69 million or -$3.46 per share.

Cash & Cash Equivalents	494.44M
Total Debt	889.70M
Net Cash	-326.69M
Net Cash Per Share	-$3.46
Equity (Book Value)	151.25M
Book Value Per Share	1.54
Working Capital	407.49M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$389.94 million and capital expenditures -$5.60 million, giving a free cash flow of -$395.54 million.

Operating Cash Flow	-389.94M
Capital Expenditures	-5.60M
Free Cash Flow	-395.54M
FCF Per Share	-$4.19

Full Cash Flow Statement

Margins

Gross margin is -30.87%, with operating and profit margins of -86.94% and -93.04%.

Gross Margin	-30.87%
Operating Margin	-86.94%
Pretax Margin	-92.63%
Profit Margin	-93.04%
EBITDA Margin	-80.90%
EBIT Margin	-86.94%
FCF Margin	n/a

Dividends & Yields

RARE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-21.44%
Shareholder Yield	-21.44%
Earnings Yield	-15.94%
FCF Yield	-11.48%

Dividend Details

Analyst Forecast

The average price target for RARE is $90.53, which is 147.89% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$90.53
Price Target Difference	147.89%
Analyst Consensus	Strong Buy
Analyst Count	15
Revenue Growth Forecast (5Y)	35.12%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

RARE has an Altman Z-Score of -2.69 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.69
Piotroski F-Score	4